Neurocrine Biosciences Inc (NBIX) Com Stk NPV (CDI)
Sell:$145.21Buy:$145.27
$1.67
(1.14%)
NASDAQ:
0.09%
0.09%Market closed |
Prices delayed by at least 15 minutes
- This stock can be held in a
Create an alert
Stocks and Shares ISASell:$145.21
Buy:$145.27
Change:$1.67
(1.14%)
$1.67
(1.14%)Market closed |
Prices delayed by at least 15 minutes
Sell:$145.21
Buy:$145.27
Change:$1.67
(1.14%)
$1.67
(1.14%)Market closed |
Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 16 December 2025 | Leslie V NorwalkIndependent Director | Sell Option/Award related | 1,190 | $155.09 | $184,558.41 | 6,239 |
| 15 December 2025 | Leslie V NorwalkIndependent Director | Sell Option/Award related | 5,000 | $152.23 | $761,143.50 | 7,429 |
| 8 December 2025 | Darin LippoldtChief Legal/Compliance Officer | Sell Option/Award related | 4,376 | $159.65 | $698,615.27 | 43,405 |
| 3 December 2025 | Gary A LyonsIndependent Director | Sell Option/Award related | 15,000 | $152.61 | $2,289,082.50 | 120,482 |
| 29 November 2025 | Jude OnyiaChief Level Officer | Sell Tax related | 2,248 | $152.16 | $342,055.68 | 15,881 |
| 28 November 2025 | Eric S. BenevichChief Level Officer | Sell Option/Award related | 5,970 | $151.74 | $905,880.64 | 44,893 |
| 25 November 2025 | George J MorrowIndependent Director | Sell Option/Award related | 15,000 | $143.37 | $2,150,512.50 | 7,068 |
| 5 November 2025 | William H. (Bill) RastetterChairman of the Board | Sell Option/Award related | 18,000 | $151.82 | $2,732,689.80 | 40,360 |
| 4 November 2025 | Kyle W. GanoPresident/CEO | Sell Tax related | 300 | $141.97 | $42,591.00 | 140,407 |
| 7 August 2025 | Kevin Charles GormanOther Level A | Sell Option/Award related | 106,322 | $126.41 | $13,440,280.97 | 514,596 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 27 January 2025 | Kevin Charles GormanOther Level A | Sell Option/Award related | 146,105 | $149.46 | $21,836,502.65 | 514,596 |
| 7 August 2025 | Kevin Charles GormanOther Level A | Sell Option/Award related | 106,322 | $126.41 | $13,440,280.97 | 514,596 |
| 15 January 2025 | Kyle W. GanoPresident/CEO | Sell Option/Award related | 60,188 | $141.50 | $8,516,656.17 | 135,392 |
| 9 July 2025 | Jude OnyiaChief Level Officer | Sell Option/Award related | 59,819 | $130.46 | $7,803,687.65 | 18,289 |
| 5 May 2025 | William H. (Bill) RastetterChairman of the Board | Sell Option/Award related | 30,000 | $110.20 | $3,305,952.00 | 37,491 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.